በTexas ለዊልምስ ቲውመር የሚደረጉ ክሊኒካዊ ጥናቶች
ለዊልምስ ቲውመር የሚደረጉ 6 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በTexas ውስጥ ያሉ ከተሞች
Official study text (English)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- እና 10 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT04715191A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Cook Children's Health Care System (Data Collection Only), Fort Worth
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT05985161Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Houston Methodist Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኖቬም 2025 · NCT06198296ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።